Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride with liposomal turmeric/resveratrol added to riluzole in ALS
2021-001989-38Phase 2Active
- Sponsor
- Universidad Católica de Valencia
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dutasteride, curcumin, resveratrol and riluzole in amyotrophic lateral sclerosis (ALS) (2 arms), sponsored by Universidad Católica de Valencia. Primary endpoint: Functional improvement by ALSFRS-R. Started Jun 2021; status: active.
02
Drugs
dutasteridecurcuminresveratrolriluzole
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2021-001989-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001989-38.